EUVIMEDEUVIMED entdecken
Crossref

Effect of hinokitiol in ameliorating oral cancer: in vitro and in silico evidences

Anitha Roy, Binoy Varghese Cheriyan, Elumalai Perumal, Kannan Rr Rengasamy iD, Shanmugam Anandakumar

Odontology · 2025

DOI: 10.1007/s10266-024-01020-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Odontology, 2025. Verfasst von Anitha Roy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Monoterpenes, Tropolone, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aimed to evaluate the anticancer potential of hinokitiol in treating oral cancer by using in vitro models and examining its interaction with the Pim-1 protein through in silico methods. Hinokitiol was applied to KB-1 oral squamous carcinoma cells, where the half-maximal inhibitory concentrations (IC50) was determined. Morphologic changes in treated cells were observed using phase contrast microscopy, while acridine orange/ethidium bromide (AO/EB) staining was used to assess nuclear changes and apoptosis. Flow cytometry was employed to analyze the cell-cycle progression. Given the high expression of Pim-1 in oral squamous carcinoma cells, molecular docking and simulation were performed to evaluate hinokitiol's binding affinity and stability with the Pim-1 protein. To compare its effects, hinokitiol was also tested on non-cancerous pre-adipocytes (3T3-L1), providing insights into its selective cytotoxicity between healthy and cancerous cells. Hinokitiol treatment resulted in cytotoxic effects on KB-1 oral squamous carcinoma cells, with an IC50 of 30 µg/mL after 24 and 48 hs of exposure. Morphologic studies showed reduced cell population and density. In contrast, hinokitiol exhibited lower toxicity and caused fewer morphological changes in non-cancerous 3T3-L1 pre-adipocytes. Apoptosis was confirmed through acridine orange/ethidium bromide staining, while flow cytometry revealed cell-cycle arrest in the Synthesis phase (S) and Gap 2 phase/ Mitosis Phase (G2/M) phases. Molecular docking showed strong binding of hinokitiol to Pim-1, and simulations confirmed the interaction's stability. These findings suggest hinokitiol selectively targets cancer cells and effectively inhibit Pim-1, supporting its potential as an oral cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsMonoterpenesTropoloneCarcinoma, Squamous CellAntineoplastic AgentsHumansMolecular Docking SimulationApoptosisCell Line, TumorIn Vitro TechniquesProto-Oncogene Proteins c-pim-1Computer SimulationFlow CytometryMiceAnimalsCell Cycle

Stichwörter der Autor:innen

HinokitiolMolecular dynamicsOral cancerPim-1

Substanzen

beta-thujaplicinMonoterpenesTropoloneProto-Oncogene Proteins c-pim-1Antineoplastic Agents

Autor:innen und Institutionen

  • Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, SIMATS, Chennai, Tamil Nadu, 600077, India.
  • Department of Pharmaceutical Chemistry, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, SIMATS, Chennai, Tamil Nadu, 602105, India. lallybinoy@gmail.com.
  • Cancer Genomics lab, Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, SIMATS, Chennai, Tamil Nadu, 602105, India.
  • Laboratory of Natural Products and Medicinal Chemistry (LNPMC), Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, SIMATS, Chennai, Tamil Nad…
  • Department of Microbiology, Dr. ALM Post Graduate Institute of Basic Medical Science, University of Madras, Chennai, Tamil Nadu, 600113, India.

ORCID-Profile: Kannan Rr Rengasamy

Zitieren

APA

Roy, A., Cheriyan, B. V., Perumal, E., Rengasamy, K. R., & Anandakumar, S. (2025). Effect of hinokitiol in ameliorating oral cancer: in vitro and in silico evidences. Odontology. https://doi.org/10.1007/s10266-024-01020-1

Vancouver

Roy A, Cheriyan BV, Perumal E, Rengasamy KR, Anandakumar S. Effect of hinokitiol in ameliorating oral cancer: in vitro and in silico evidences. Odontology. 2025. doi:10.1007/s10266-024-01020-1

BibTeX
@article{Roy2025,
  author = {Roy, Anitha and Cheriyan, Binoy Varghese and Perumal, Elumalai and Rengasamy, Kannan Rr and Anandakumar, Shanmugam},
  title = {Effect of hinokitiol in ameliorating oral cancer: in vitro and in silico evidences},
  journal = {Odontology},
  year = {2025},
  doi = {10.1007/s10266-024-01020-1}
}
Kostenlos starten →